| scholarly article | Q13442814 |
| P50 | author | Wendi S. Lambert | Q92534832 |
| P2093 | author name string | David J Calkins | |
| Brian J Carlson | |||
| Purnima Ghose | |||
| Vincent Yao | |||
| Victoria D Vest | |||
| P2860 | cites work | The number of people with glaucoma worldwide in 2010 and 2020 | Q24679554 |
| Targeting amyloid-beta in glaucoma treatment. | Q24681763 | ||
| Senile Dementia and Glaucoma: Evidence for a Common Link | Q26783439 | ||
| Critical pathogenic events underlying progression of neurodegeneration in glaucoma | Q26859194 | ||
| Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases | Q27007111 | ||
| Fiji: an open-source platform for biological-image analysis | Q27860912 | ||
| The classical complement cascade mediates CNS synapse elimination | Q28261273 | ||
| Microglia-specific localisation of a novel calcium binding protein, Iba1 | Q28273977 | ||
| Biomechanical aspects of axonal damage in glaucoma: A brief review | Q30490933 | ||
| Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension | Q31776046 | ||
| Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes | Q33234966 | ||
| Decrease of cone opsin mRNA in experimental ocular hypertension. | Q33263876 | ||
| Animals as models of age-related macular degeneration: an imperfect measure of the truth | Q33552165 | ||
| Animal models of choroidal and retinal neovascularization | Q33582933 | ||
| Distal axonopathy with structural persistence in glaucomatous neurodegeneration | Q33740029 | ||
| Interleukin-6 Deficiency Attenuates Retinal Ganglion Cell Axonopathy and Glaucoma-Related Vision Loss. | Q33743591 | ||
| The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice | Q33847407 | ||
| The morphology and spatial arrangement of astrocytes in the optic nerve head of the mouse. | Q33975340 | ||
| Intraocular pressure magnitude and variability as predictors of rates of structural change in non-human primate experimental glaucoma | Q34409191 | ||
| Connecting the retina to the brain | Q34453720 | ||
| Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors | Q34545452 | ||
| Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice | Q34551476 | ||
| The Microbead Occlusion Model of Ocular Hypertension in Mice. | Q47225888 | ||
| Anterograde Tract Tracing for Assaying Axonopathy and Transport Deficits in Glaucoma | Q49490126 | ||
| Hypertonic Saline Injection Model of Experimental Glaucoma in Rats | Q49490204 | ||
| Horizontal cells and cone photoreceptors in primate retina: a Golgi-light microscopic study of spectral connectivity. | Q50772656 | ||
| Marijuana-derived material-induced changes in monkey ciliary processes differ from those in rabbit ciliary processes. | Q52482889 | ||
| Structural and Functional Rescue of Chronic Metabolically Stressed Optic Nerves through Respiration | Q56936883 | ||
| New MiniPromoter Ple345 (NEFL) Drives Strong and Specific Expression in Retinal Ganglion Cells of Mouse and Primate Retina | Q57046354 | ||
| Intraocular pressure following long posterior ciliary canal cautery in primates | Q67291261 | ||
| The topography of primate retina: a study of the human, bushbaby, and new- and old-world monkeys | Q70730779 | ||
| Chronic experimental glaucoma in primates. I. Production of elevated intraocular pressure by anterior chamber injection of autologous ghost red blood cells | Q71492592 | ||
| Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport | Q72604001 | ||
| Neurochemical compartmentation of monkey and human visual cortex: similarities and variations in calbindin immunoreactivity across species | Q72648661 | ||
| Tear production after unilateral removal of the main lacrimal gland in squirrel monkeys | Q73453484 | ||
| Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma | Q73535458 | ||
| Neuroinflammatory Cytokines Induce Amyloid Beta Neurotoxicity through Modulating Amyloid Precursor Protein Levels/Metabolism | Q93379781 | ||
| Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse. | Q34646704 | ||
| Cell Proliferation and Interleukin-6–Type Cytokine Signaling Are Implicated by Gene Expression Responses in Early Optic Nerve Head Injury in Rat Glaucoma | Q34646791 | ||
| Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure | Q34953629 | ||
| Gene therapy for red-green colour blindness in adult primates | Q35003425 | ||
| Glaucoma: ocular Alzheimer's disease? | Q35212894 | ||
| Chronic IL-1β-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer's disease without inducing overt neurodegeneration | Q35827454 | ||
| Early pro-inflammatory cytokine elevations in the DBA/2J mouse model of glaucoma | Q36071513 | ||
| Primate glaucoma models | Q36180431 | ||
| Failure of axonal transport induces a spatially coincident increase in astrocyte BDNF prior to synapse loss in a central target | Q36501562 | ||
| Experimental glaucoma in the rhesus monkey | Q36507247 | ||
| Spatial regulation of interleukin-6 signaling in response to neurodegenerative stressors in the retina | Q36576462 | ||
| Laser energy levels for trabecular meshwork damage in the primate eye. | Q36635756 | ||
| Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma | Q36639100 | ||
| Macular Structure and Function in Nonhuman Primate Experimental Glaucoma. | Q36849371 | ||
| Acute and subacute IL-1β administrations differentially modulate neuroimmune and neurotrophic systems: possible implications for neuroprotection and neurodegeneration | Q36851799 | ||
| Proximal inhibition of p38 MAPK stress signaling prevents distal axonopathy | Q37179493 | ||
| Early Cytoskeletal Protein Modifications Precede Overt Structural Degeneration in the DBA/2J Mouse Model of Glaucoma | Q37389519 | ||
| Absence of transient receptor potential vanilloid-1 accelerates stress-induced axonopathy in the optic projection | Q37603758 | ||
| Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma. | Q37627081 | ||
| Neurotrophic factor delivery as a protective treatment for glaucoma | Q37777778 | ||
| Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy | Q38004641 | ||
| The complex role of neuroinflammation in glaucoma | Q38226119 | ||
| Central visual pathways in glaucoma: evidence for distal mechanisms of neuronal self-repair | Q38566812 | ||
| Neuroinflammation in Glaucoma and Optic Nerve Damage | Q38574387 | ||
| Biological aspects of axonal damage in glaucoma: A brief review | Q39145713 | ||
| The connective tissue phenotype of glaucomatous cupping in the monkey eye - Clinical and research implications. | Q39181801 | ||
| Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma. | Q39735894 | ||
| Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma. | Q39788214 | ||
| The retinal ganglion cell classes of New World primates | Q41658410 | ||
| Automated Axon Counting in Rodent Optic Nerve Sections with AxonJ. | Q42131560 | ||
| Regional Retinal Ganglion Cell Axon Loss in a Murine Glaucoma Model | Q42228757 | ||
| Neuroinflammation in advanced canine glaucoma. | Q42395481 | ||
| Structural basis of glaucoma: the fortified astrocytes of the optic nerve head are the target of raised intraocular pressure | Q42495009 | ||
| Rats and humans differ in processing collinear visual features | Q42797277 | ||
| Experimental glaucoma in the primate induced by latex microspheres | Q43748731 | ||
| The squirrel monkey: characterization of a new-world primate model of experimental choroidal neovascularization and comparison with the macaque. | Q44743319 | ||
| Number and topography of cones, rods and optic nerve axons in New and Old World primates | Q46504098 | ||
| Retrograde axonal transport obstruction of brain-derived neurotrophic factor (BDNF) and its TrkB receptor in the retina and optic nerve of American Cocker Spaniel dogs with spontaneous glaucoma | Q46921491 | ||
| Role of BDNF/TrkB pathway in the visual system: Therapeutic implications for glaucoma | Q47146770 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 11572 | |
| P577 | publication date | 2019-08-09 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Towards A Microbead Occlusion Model of Glaucoma for a Non-Human Primate | |
| P478 | volume | 9 |
| Q99207552 | Longitudinal assessment of optic nerve head changes using optical coherence tomography in a primate microbead model of ocular hypertension |
| Q95660650 | Of Mice and Monkeys: Neuroprotective Efficacy of the p38 Inhibitor BIRB 796 Depends on Model Duration in Experimental Glaucoma |
| Q92217460 | The primate model for understanding and restoring vision |
Search more.